MHR Fund Management LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), MHR Fund Management LLC reported 10 stock positions worth $1.0 billion. Its top holding was Iovance Biotherapeutics (IOVA) at 34.4% of the portfolio, followed by Lions Gate Entmnt (19.4%) and Telesat (TSAT, 14.8%). Compared with Q4 2023, it added to 1. The biggest buy was Iovance Biotherapeutics (IOVA, shares +20%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001277742
Portfolio Value
$1.0B (Q1 2024)
SEC Filing
0001011438-24-000362 ↗ filed May 15, 2024

Holdings Value

0$500.0M$1.0B$1.5B$2.0B Q1 2024: $1.0B $1.0B Q1 2024 Q2 2024: $820.6M Q2 2024 Q3 2024: $917.0M Q3 2024 Q4 2024: $904.4M Q4 2024 Q1 2025: $832.0M Q1 2025 Q2 2025: $901.6M Q2 2025 Q3 2025: $1.0B Q3 2025 Q4 2025: $1.2B Q4 2025 Q1 2026: $1.4B Q1 2026 Q2 2026: $1.9B Q2 2026

Holdings 10 stocks · $1.0B
IOVA Iovance Biotherapeutics Inc. 34.36% 23,997,103 $355.6M Add +20.0%
LIONS GATE ENTMNT CORP 19.35% 20,127,661 $200.3M No change
TSAT Telesat Corp. 14.85% 18,035,092 $153.7M No change
LGF.B Lions Gate Entertainment-B 13.59% 15,105,523 $140.6M No change
TWI Titan International Inc. 9.64% 8,005,000 $99.7M No change
APO Apollo Global Management Inc. 7.38% 679,000 $76.4M No change
SCHL Scholastic Corp. 0.47% 130,000 $4.9M No change
MSGS Madison Square Garden Sports 0.27% 15,001 $2.8M No change
DVAX Dynavax Technologies Corp. 0.05% 44,499 $552K No change
OPTU Optimum Communications Inc. Class A filed as ALTICE USA INC 0.04% 167,800 $438K No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
IOVA Iovance Biotherapeutics Inc. Add +20.0% 34.36% +16.60

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 11$1.9BTSAT, LION, HAFN, IOVA, STRZ
Q1 2026 10$1.4BTSAT, LION, HAFN, IOVA, APO
Q4 2025 10$1.2BTSAT, LION, HAFN, IOVA, APO
Q3 2025 10$1.0BTSAT, LION, HAFN, IOVA, APO
Q2 2025 9$901.6MTSAT, LION, HAFN, APO, IOVA
Q1 2025 9$832.0MTSAT, LIONS GATE ENTMNT CORP, LGF.B, IOVA, APO
Q4 2024 9$904.4MTSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO
Q3 2024 9$917.0MTSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO
Q2 2024 9$820.6MIOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, APO
Q1 2024 10$1.0BIOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, TWI